Global Pharma ADMET Testing Market Report 2024

Pharma ADMET Testing Global Market Report 2025 – By Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing), By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Pharma ADMET Testing Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pharma ADMET Testing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pharma ADMET Testing Market Definition

Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use.

The main types of pharma ADMET testing are in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In vivo ADMET testing refers to the assessment of a drug's absorption, distribution, metabolism, excretion, and toxicity properties within a living organism. Pharma ADMET testing is used in drug discovery and development processes to identify potential drug candidates with desirable pharmacokinetic properties. The technologies include cell culture, high throughput, molecular imaging, and OMICS technology which are used in systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others.

Pharma ADMET Testing Market Segmentation

The pharma ADMET testing market covered in this report is segmented –

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Subsegments:

1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing

3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

Pharma ADMET Testing Market Size and growth rate 2025 to 2029: Graph

Pharma ADMET Testing Market Size 2025 And Growth Rate

The pharma ADMET testing market size has grown rapidly in recent years. It will grow from $9.67 billion in 2024 to $10.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling

Pharma ADMET Testing Market Growth Forecast

The pharma ADMET testing market size is expected to see rapid growth in the next few years. It will grow to $17.1 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (AI), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, and environmental impact considerations.

Pharma ADMET Testing Market Driver: The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market

The rising number of product approvals is driving the pharma ADMET testing market. Product approvals refer to the process by which regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is beneficial for determining the safety and efficacy of novel products and is mandatory in product regulatory approvals. For instance, in January 2024, according to the National Library of Medicine, a US-based biomedical library and a national resource for health professionals, there were 55 new drugs approved by the U.S. Food and Drug Administration (FDA) in 2023, up from 37 drugs approved in 2022. Therefore, the rising number of product approvals drives the pharma ADMET testing market.

Pharma ADMET Testing Market Driver: The Impact Of Escalating Clinical Trials On The Pharma ADMET Testing Market

The increase in the number of clinical trials is expected to boost the growth of the pharma ADMET testing market going forward. A clinical trial is a research study conducted with human participants to evaluate the safety, efficacy, and potential side effects of a medical intervention, such as a new drug, medical device, diagnostic procedure, or treatment regimen. The upswing in clinical trials markedly elevates the demand for thorough assessments of drug safety and efficacy within the pharma ADMET testing market, emphasizing the critical need for tailored evaluations across diverse drug candidates and patient populations. For instance, in May 2023, according to a report published by Xtalks, a Canada-based web news and information network, 452,604 clinical studies have been registered on ClinicalTrials.gov as of May 2023. This marks a significant rise from the more than 365,000 registered trials that were recorded in early 2021. Therefore, the increase in the number of clinical trials is driving the growth of the pharma ADMET testing market.

Global Pharma ADMET Testing Market Major Players

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Global Pharma ADMET Testing Market Trend: The Impact Of Product Innovations On The Pharma ADMET Testing Market

Product innovations are a key trend gaining popularity in the pharma ADMET testing market. Major companies in the pharma ADMET testing market are introducing innovative products such as Logica to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, launched Logica, an AI-based drug development solution. The new solution leverages Valo's AI-powered Opal Computational Platform to provide users with ADMET testing services and other drug delivery solutions. Logica makes use of industry-leading predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo's Opal Computational Platform, in addition to the Charles River’s leading capabilities in all aspects of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission.

Global Pharma ADMET Testing Market Trend: Strategic Partnerships Drive Progress In The Pharma ADMET Testing Market

Major companies operating in the pharma ADMET testing market are adopting a strategic partnership approach to improve efforts in discovering allosteric drugs. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in May 2022, Excelra, a US-based company that accelerates drug discovery and development leveraging advanced data science, partnered with HotSpot Therapeutics Inc., a US-based biotechnology company that develops small molecule allosteric therapies. The partnership aims to boost HotSpot's drug discovery and development initiatives by integrating Excelra's premier product, GOSTAR, and its meticulously annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models. Through the incorporation of GOSTAR data, HotSpot seeks to propel the exploration and creation of small molecule therapeutic candidates targeted at allosteric sites that have traditionally posed challenges for drug development using conventional approaches. GOSTAR offers a comprehensive perspective on over 8 million small molecules, providing the latest insights into the chemical space, encompassing details on chemical structures and diverse biological properties, including binding, in vitro, in vivo, ADME, toxicology, and physicochemical properties.

Pharma ADMET Testing Market Merger And Acquisition: BioIVT Acquired Xenotech

In September 2022, BioIVT, a US-based drug development solutions provider, acquired XenoTech for an undisclosed amount. The acquisition complements the product portfolio of BioIVT and helps it expand its product offerings in newer geographies and to a broader customer base. XenoTech is a US-based contract research organization providing ADMET testing services.

Regional Outlook For The Global Pharma ADMET Testing Market

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma ADMET testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharma ADMET Testing Market?

The pharma ADMET testing market consists of revenues earned by entities by providing services such as in vitro screening, in vitro metabolism, and metabolite testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma ADMET testing market also includes the sales of membranes, buffer systems, and analytes that are used in the assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharma ADMET Testing Industry?

The pharma ADMET testing market research report is one of a series of new reports from The Business Research Company that provides pharma ADMET testing market statistics, including the pharma ADMET testing industry's global market size, regional shares, competitors with a pharma ADMET testing market share, detailed pharma ADMET testing market segments, market trends, and opportunities, and any further data you may need to thrive in the pharma ADMET testing industry. This pharma ADMET testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharma ADMET Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $10.73 billion
Revenue Forecast In 2034 $17.1 billion
Growth Rate CAGR of 12.4% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications Subsegments: 1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharma ADMET Testing Market Characteristics

    3. Pharma ADMET Testing Market Trends And Strategies

    4. Pharma ADMET Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Pharma ADMET Testing Growth Analysis And Strategic Analysis Framework

    5.1. Global Pharma ADMET Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Pharma ADMET Testing Market Growth Rate Analysis

    5.4. Global Pharma ADMET Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Pharma ADMET Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Pharma ADMET Testing Total Addressable Market (TAM)

    6. Pharma ADMET Testing Market Segmentation

    6.1. Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    In Vivo ADMET Testing

    In Vitro ADMET Testing

    In Silico ADMET Testing

    6.2. Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cell Culture

    High Throughpu

    Molecular Imaging

    OMICS Technology

    6.3. Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Systemic Toxicity

    Renal Toxicity

    Hepatotoxicity

    Neurotoxicity

    Other Applications

    6.4. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Animal Studies

    Pharmacokinetics Studies

    Toxicology Studies

    Biodistribution Studies

    6.5. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Metabolism Studies

    Drug-Drug Interaction Studies

    Absorption Studies

    Cytotoxicity and Safety Testing

    6.6. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Predictive Modeling and Simulation

    Quantitative Structure-Activity Relationship (QSAR) Analysis

    Machine Learning Algorithms for ADMET Predictions

    Software Tools for ADMET Profiling

    7. Pharma ADMET Testing Market Regional And Country Analysis

    7.1. Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Pharma ADMET Testing Market

    8.1. Asia-Pacific Pharma ADMET Testing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Pharma ADMET Testing Market

    9.1. China Pharma ADMET Testing Market Overview

    9.2. China Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Pharma ADMET Testing Market

    10.1. India Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Pharma ADMET Testing Market

    11.1. Japan Pharma ADMET Testing Market Overview

    11.2. Japan Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Pharma ADMET Testing Market

    12.1. Australia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Pharma ADMET Testing Market

    13.1. Indonesia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Pharma ADMET Testing Market

    14.1. South Korea Pharma ADMET Testing Market Overview

    14.2. South Korea Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Pharma ADMET Testing Market

    15.1. Western Europe Pharma ADMET Testing Market Overview

    15.2. Western Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Pharma ADMET Testing Market

    16.1. UK Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Pharma ADMET Testing Market

    17.1. Germany Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Pharma ADMET Testing Market

    18.1. France Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Pharma ADMET Testing Market

    19.1. Italy Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Pharma ADMET Testing Market

    20.1. Spain Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Pharma ADMET Testing Market

    21.1. Eastern Europe Pharma ADMET Testing Market Overview

    21.2. Eastern Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Pharma ADMET Testing Market

    22.1. Russia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Pharma ADMET Testing Market

    23.1. North America Pharma ADMET Testing Market Overview

    23.2. North America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Pharma ADMET Testing Market

    24.1. USA Pharma ADMET Testing Market Overview

    24.2. USA Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Pharma ADMET Testing Market

    25.1. Canada Pharma ADMET Testing Market Overview

    25.2. Canada Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Pharma ADMET Testing Market

    26.1. South America Pharma ADMET Testing Market Overview

    26.2. South America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Pharma ADMET Testing Market

    27.1. Brazil Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Pharma ADMET Testing Market

    28.1. Middle East Pharma ADMET Testing Market Overview

    28.2. Middle East Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Pharma ADMET Testing Market

    29.1. Africa Pharma ADMET Testing Market Overview

    29.2. Africa Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles

    30.1. Pharma ADMET Testing Market Competitive Landscape

    30.2. Pharma ADMET Testing Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. PPD ICON plc Overview, Products and Services, Strategy and Financial Analysis

    31. Pharma ADMET Testing Market Other Major And Innovative Companies

    31.1. Agilent Technologies Inc.

    31.2. Wuxi AppTec Co. Ltd.

    31.3. Catalent Inc.

    31.4. Covance Inc.

    31.5. Charles River Laboratories International Inc.

    31.6. Eurofins Scientific SE

    31.7. Beckman Coulter Inc.

    31.8. Perkinelmer Inc.

    31.9. Albany Molecular Research Inc.

    31.10. Evotec A.G.

    31.11. CMIC Holdings Co. Ltd.

    31.12. Promega Corporation

    31.13. Aptuit LLC

    31.14. Symeres B.V.

    31.15. Biovia Corp.

    32. Global Pharma ADMET Testing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

    34. Recent Developments In The Pharma ADMET Testing Market

    35. Pharma ADMET Testing Market High Potential Countries, Segments and Strategies

    35.1 Pharma ADMET Testing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Pharma ADMET Testing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Pharma ADMET Testing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: The Merck Group Financial Performance
  • Table 79: Laboratory Corporation of America Holdings Financial Performance
  • Table 80: IQVIA Inc. Financial Performance
  • Table 81: PPD ICON plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: The Merck Group Financial Performance
  • Figure 79: Laboratory Corporation of America Holdings Financial Performance
  • Figure 80: IQVIA Inc. Financial Performance
  • Figure 81: PPD ICON plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Pharma ADMET Testing market?

Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use. For further insights on the Pharma ADMET Testing market, request a sample here

How will the Pharma ADMET Testing market drivers and restraints affect the market dynamics? What forces will shape the Pharma ADMET Testing industry going forward?

The Pharma ADMET Testing market major growth driver - The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market. For further insights on the Pharma ADMET Testing market, request a sample here

What is the forecast market size or the forecast market value of the Pharma ADMET Testing market?

The Pharma ADMET Testing market size has grown strongly in recent years. The pharma ADMET testing market size has grown rapidly in recent years. It will grow from $9.67 billion in 2024 to $10.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling The pharma ADMET testing market size is expected to see rapid growth in the next few years. It will grow to $17.1 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (AI), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, and environmental impact considerations. For further insights on the Pharma ADMET Testing market, request a sample here

How is the Pharma ADMET Testing market segmented?

The pharma ADMET testing market covered in this report is segmented –
1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications Subsegments:
1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling For further insights on the Pharma ADMET Testing market,
request a sample here

Which region has the largest share of the Pharma ADMET Testing market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pharma ADMET Testing market, request a sample here.

Who are the major players in the Pharma ADMET Testing market?

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc. . For further insights on the Pharma ADMET Testing market, request a sample here.

What are the key trends in the Pharma ADMET Testing market?

Major trends in the Pharma ADMET Testing market include The Impact Of Product Innovations On The Pharma ADMET Testing Market. For further insights on the Pharma ADMET Testing market, request a sample here.

What are the major opportunities in the Pharma ADMET Testing market? What are the strategies for the Pharma ADMET Testing market?

For detailed insights on the major opportunities and strategies in the Pharma ADMET Testing market, request a sample here.

How does the Pharma ADMET Testing market relate to the overall economy and other similar markets?

For detailed insights on Pharma ADMET Testing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharma ADMET Testing industry?

For detailed insights on the mergers and acquisitions in the Pharma ADMET Testing industry, request a sample here.

What are the key dynamics influencing the Pharma ADMET Testing market growth? SWOT analysis of the Pharma ADMET Testing market.

For detailed insights on the key dynamics influencing the Pharma ADMET Testing market growth and SWOT analysis of the Pharma ADMET Testing industry, request a sample here.